Stock comparison
Edwards Lifesciences
EW$51.43BHealthcare Market cap, Sector
SANOFI CONS HEALTHC IND L
SANOFICONR.NS$104.57BHealthcare Market cap, Sector
Overall winner
SANOFI CONS HEALTHC IND L
EW 16 SANOFICONR.NS
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
Fit scores by strategy
EW1wins
6winsSANOFICONR.NS
63C
B78
91A
A89
64C
B83
28F
B77
56D
A91
73B
A86
72B
A85
Side-by-side metrics
| Metric | EW | SANOFICONR.NS |
|---|---|---|
| Market cap | $51.43B | $104.57B Winner |
| P/E (TTM) | Winner: 43.2x | 44.2x |
| EV/EBIT | Winner: 27.6x | 31.8x |
| ROIC (TTM) | 12.06% | 59.15% Winner |
| Gross margin | Winner: 78.01% | 68.13% |
| Net margin | 17.34% | 27.35% Winner |
| Revenue CAGR 5y | 3.77% | 27.01% Winner |
| EPS CAGR 5y | -6.52% | 20.67% Winner |
| Debt / Equity | 0.1x | 0.1x Winner |
| Dividend yield | 0.0% | - |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
EW leads on
- EV/EBIT27.6xvs 31.8x+13%
- Gross margin78.01%vs 68.13%+13%
SANOFICONR.NS leads on
- EPS CAGR 5y20.67%vs -6.52%+132%
- Revenue CAGR 5y27.01%vs 3.77%+86%
- ROIC (TTM)59.15%vs 12.06%+80%
- Market cap$104.57Bvs $51.43B+51%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.